Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy

Transplantation

Volumn 75, Issue 8, 2003, Pages 1396-1399

  Eason, James D ^a   Nair, Satheesh ^a   Cohen, Ari J ^a   Blazek, Jamie L ^a   Loss Jr , George E ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RABBIT ANTITHYMOCYTE GLOBULIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RABBIT; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANIMALS; ANTILYMPHOCYTE SERUM; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; RABBITS; SURVIVAL ANALYSIS; TACROLIMUS;

EID: 0037469018     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000062834.30922.FE     Document Type: Conference Paper

References (24)

1. Eason JD, Loss GE, Blazek JL, et al. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial. Liver Transpl 2001; 7(8): 693.
2. Eason JD, Blazek J, Mason A, et al. Steroid-free immunosuppression through Thymoglobulin induction in liver transplantation. Transplant Proc 2001; 33: 1470.
3. Singh N, Gayowski T, Ndimbie OK, et al. Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: association with rejection and increased immunosuppression after transplantation. Surgery 1996; 119: 452.
4. Stegall MD, Everson G, Schroter G, et al. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension and obesity. Transplantation 1995; 60: 1057.
5. Jindal RM, Sidner RA, Hughes D, et al. Metabolic problems in recipients of liver transplants. Clin Transpl 1996; 10: 213.
6. Sheiner PA, Schwarz ME, Mor E, et al. Severe or multiple rejection episodes is associated with early recurrence of hepatitis C following orthotopic liver transplantation. Hepatology 1995; 21: 30.
7. Goddard S, Adams DH. Methylprednisolone therapy for acute rejection: Too much of a good thing? Liver Transpl 2002; 8(6): 535.
8. Eason J, Cosimi AB: Biologic immunosuppressive agents. In: Ginns LC, Cosimi AB, Morris PJ, eds. Transplantation. Malden, MA: Blackwell Sciences 1999, p 196.
9. Wall WJ. Use of antilymphocyte induction therapy in liver transplantation. Liver Transpl Surg 1999; 5(4 suppl 1): 64.
10. McVicar JP, Kowdley KV, Emond MJ, et al. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation. Clin Transpl 1997; 11: 328.
11. Langrehr JM, Nussler NC, Neumann U, et al. A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation. Transplantation 1997; 63: 1772.
12. Fraser GM, Grammoustianos K, Reddy J, et al. Long-term immunosuppression without corticosteroids after orthotopic liver transplantation: a positive therapeutic aim. Liver Transpl Surg 1996; 2: 411.
13. Trouillot TE, Shrestha R, Kam I, et al. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis. Liver Transpl Surg 1999; 5: 375.
14. Stegall MD, Wachs ME, Everson G, et al. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. Transplantation 1997; 64(12): 1755.
15. Rolles K, Davidson BR, Burroughs AK. A pilot study of immunosuppressive monotherapy in liver transplantation; tacrolimus versus microemulsified cyclosporin. Transplantation 1999; 68: 1195.
16. Tisone G, Angelico M, Palmieri G, et al. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Transplantation 1999; 67: 1308.
17. Pinzello G, Belli LS, Alberti AB, et al. Early ribavirin treatment and avoidance of steroids in HCV positive liver transplant recipients: interim report of a prospective randomized trial. Transplant Proc 2001; 33: 1353.
18. Ringe B, Braun F, Schutz E, et al. A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation 2001; 71: 508.
19. Washburn K, Speeg KV, Esterl R, et al. Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil. Transplantation 2001; 72(10): 1675.
20. Boillot O, Viale JP, Gratadour P, et al. Reversal of early acute rejection with increased doses oftacrolimus in liver transplantation. Transplantation 1998; 66: 1182.
21. Jain AB, Hamad I, Rakela J, et al. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients. Transplantation 1998; 66: 1395.
22. Papatheodoridis GV, Davies S, Dhillon AP, et al. The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis. Transplantation 2001; 72: 412.
23. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256.
24. Wang C, Sun J, Sheil AG, et al. A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation 2001; 72: 44.